Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M
April 29, 2014 at 07:08 AM EDT
Advances Discovery Strategy to Pursue Therapeutics for Genetically Defined Diseases Gains Full Rights to IPN007, a Promising ...